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Abstract
Background: Disseminating palliative care is a critical task throughout the world. Several outcome studies explored
the effects of regional palliative care programs on a variety of end-points, and some qualitative studies investigated
the process of developing community palliative care networks. These studies provide important insights into the
potential benefits of regional palliative care programs, but the clinical implications are still limited, because: 1)
many interventions included fundamental changes in the structure of the health care system, and, thus, the results
would not be applicable for many regions where structural changes are difficult or unfeasible; 2) patient-oriented
outcomes were not measured or explored only in a small number of populations, and interpretation of the results
from a patient’s view is difficult; and 3) no studies adopted a mixed-method approach using both quantitative and
qualitative methodologies to interpret the complex phenomenon from multidimensional perspectives.
Methods/designs: This is a mixed-method regional intervention trial, consisting of a pre-post outcome study and
qualitative process studies. The primary aim of the pre-post outcome study is to evaluate the change in the
number of home deaths, use of specialized palliative care services, patient-reported quality of palliative care, and
family-reported quality of palliative care after regional palliative care intervention. The secondary aim is to explore
the changes in a variety of outcomes, including patients’ quality of life, pain intensity, family care burden, and
physicians’ and nurses’ knowledge, difficulties, and self-perceived practice. Outcome measurements used in this
study include the Care Evaluation Scale, Good Death Inventory, Brief pain Inventory, Caregiving Consequence
Inventory, Sense of Security Scale, Palliative Care Knowledge test, Palliative Care Difficulties Scale, and Palliative Care
Self-reported Practice Scale. Study populations are a nearly representative sample of advanced cancer patients,
bereaved family members, physicians, and nurses in the region.
Qualitative process studies consist of 3 studies with each aim: 1) to describe the process in developing regional
palliative care in each local context, 2) to understand how and why the regional palliative care program led to
changes in the region and to propose a model for shaping regional palliative care, and 3) to systemically collect
the barriers of palliative care at a regional level and potential resolutions. The study methodology is a case
descriptive study, a grounded theory approach based on interviews, and a content analysis based on systemically
collected data, respectively.
Discussion: This study is, to our knowledge, one of the most comprehensive evaluations of a region-based
palliative care intervention program. This study has 3 unique aspects: 1) it measures a wide range of outcomes,
including quality of care and quality of life measures specifically designed for palliative care populations, whether
patients died where they actually preferred, the changes in physicians and nurses at a regional level; 2) adopts
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any medium, provided the original work is properly cited.qualitative studies along with quantitative evaluations; and 3) the intervention is without a fundamental change in
health care systems. A comprehensive understanding of the findings in this study will contribute to a deeper
insight into how to develop community palliative care.
Trial Registration: UMIN Clinical Trials Registry (UMIN-CTR), Japan, UMIN000001274.
Background
Palliative care is an essential part of integrated cancer
treatment [1]. Palliative care should be provided
throughout an entire region, and several outcome stu-
dies have explored the effects of regional palliative care
programs on places of death, the use of palliative care
resources, patient-reported outcomes, family-reported
outcomes, and cost [2-9]. In a cluster randomized con-
trolled trial, a regional palliative care intervention,
including developing a specialized inpatient palliative
care service at an academic hospital, strengthening the
cooperation between specialized palliative care and com-
munity health care services, developing clinical guide-
lines, and educational programs for community health
care providers, contributed to an increase in the number
of home deaths and higher levels of family satisfaction,
but the patient-reported quality of life, measured by the
EORTC-C30, was not significantly different [2-4]. A pio-
neer work as a regional palliative care model, the
Edmonton program, observed that constructing a novel
regional system, including a regional palliative care
office to coordinate palliative care activities at specialist
and community levels throughout the region, resulted in
an increased number of home deaths and use of specia-
lized palliative care services [5,6]. A recent palliative
care quality improvement project in Ontario included
developing and disseminating standard clinical tools for
collaborative care planning and symptom assessment
[7,8]. The audit study from this project demonstrated an
increased documentation of symptoms and decreased
use of emergency visits, while the symptom intensity
and family satisfaction did not significantly improve. In
addition, the Catalonia WHO demonstration project
demonstrated an increase in the quantity and variety of
specialized palliative care services and potential cost-sav-
ing effects [9]. More recently, the U.K. implemented the
Gold Standards Framework, stressing communication
and coordination in the community through developing
a palliative care patient registry and regular meetings
[10-13]. Qualitative studies suggest the most important
benefit of the Gold Standards Framework is facilitating
communication among health care professionals in the
community, although the direct effects on patient and/
or family outcomes were formally unmeasured. Multiple
studies from Canada, the Netherlands, and Australia
which investigated the process of developing community
palliative care networks again revealed the perceived
importance of an increase in personal and formal con-
tacts in health care professionals [14-16].
These studies provide important insights into the
potential benefits of regional palliative care programs,
but the clinical implications are still limited, because: 1)
the interventions included a fundamental change in the
structure of the health care system (Norway, Edmonton,
Catalonia, and the U.K.), and, thus, the results would
not be applicable for many regions where structural
changes are difficult or unfeasible; 2) patient-oriented
outcomes were not measured or explored only in a
small number of populations, and interpretation of the
results from a patient’s view is difficult; and 3) no stu-
dies adopted the mixed-method approach using both
quantitative and qualitative methodologies to interpret
the complex phenomenon from multidimensional per-
spectives [17-20].
We believe, therefore, that a new study should
include: 1) an intervention program available for many
regions without fundamental changes to the health care
system, 2) adequate patient-oriented outcomes, and 3)
qualitative studies along with quantitative evaluation.
The aim of this presentation is to describe a study
protocol of a region-based palliative care intervention
trial using the mixed-method approach: the Outreach
Palliative care Trial of Integrated Model (OPTIM study)
from Japan.
Methods and Design
Overview and aims
This is a regional intervention trial, consisting of a pre-
post outcome study and qualitative process studies.
Initially, this study was designed as a cluster randomized
controlled trial, but we have decided to adopt a mixed-
method design because: 1) intervention itself should be
applied to all populations over the country and a clear
distinction between intervention and control groups is
difficult [20], 2) a concealment problem is likely to
occur [2-4], and 3) the most important mission at a
national level is not to clarify if one specific intervention
actually changes outcomes, but to obtain comprehensive
insights into how to disseminate palliative care through-
out the country [17,18].
The primary aim of the pre-post outcome study is to
evaluate the change in the number of home deaths, use
of specialized palliative care services, patient-reported
quality of palliative care, and family-reported quality of
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The secondary aims are to explore the changes in a vari-
ety of outcomes, including the distribution of locations
of death; patient- and/or family-reported quality of life,
whether patients died where they actually preferred,
time spent at home, satisfaction, pain, care burden;
knowledge, belief, and concerns about palliative care;
and knowledge, difficulties, and self-reported practice
about palliative care of physicians and nurses. Qualita-
tive process studies are performed to obtain a deep
insight into how and why the regional palliative care
program does or does not work.
Data for the pre-post outcome study were collected in
2007-2008 as pre-intervention data and in 2010-2011 as
post-intervention data. Data for qualitative studies were
collected throughout the study periods.
Ethical and scientific validity was confirmed by the
institutional review board of this study and all partici-
pating institutions.
Setting
To explore the potential influence of the variations in
the existing health care system, we have decided to con-
duct this trial in 4 regions with different palliative care
systems across Japan: Tsuruoka (170,000 population,
Yamagata Prefecture), Kashiwa (670,000 population,
Chiba Prefecture), Hamamatsu (820,000 population, Shi-
zuoka Prefecture), and Nagasaki (450,000 population,
Nagasaki Prefecture). Kashiwa and Hamamatsu have
specialized hospital palliative care teams in a cancer
center and general hospitals, respectively; Nagasaki has a
coordinated palliative care system for home patients in
addition to hospital palliative care teams; and Tsuruoka
has no formal specialized palliative care service at the
beginning of the study.
Interventions
Designing interventions
Interventions were designed on the basis of literature
review, preliminary survey, and discussion among the
researchers and clinical practitioners from the study
regions [21-33].
To construct a conceptual framework, we initially
reviewed the existing domestic and international litera-
ture available to identify barriers to provide quality pal-
liative care [21-23], and performed a preliminary survey
of 8,000 general public and 8,000 medical health care
providers in the 4 regions before planning the interven-
tions [24]. The task force then drafted the intervention
protocol with close collaborative with representative
health care providers from the 4 regions, and has fina-
lized intervention protocol. The intervention protocol
describes the minimum requirements for this study to
allow it to meet the specific situations of regions [19,20].
To deliver the intervention, each region is asked to
establish a “regional palliative care center” with several
local leaders, who receive a start-up 2-day workshop
from the study team before intervention with continu-
ous follow-up. Local leaders include physicians, nurses,
and medical social workers who have already been
working as a clinical specialist in the region. Further-
more, local leaders foster link-staffs at each regional
level. To facilitate interventions, meetings among local
leaders are planned to be held about 25 times during
this study period; a certified community nurse visits
each region and followed up by telephone and e-mail as
a facilitator; and interactive conferences among link-
staffs from the 4 regions are held 3 times.
The interventions include 4 areas: 1) to improve the
knowledge and skills of palliative care providers, 2) to
increase the availability of specialized palliative care ser-
vices for community patients, 3) to coordinate commu-
nity palliative care resources, and 4) to provide
appropriate information about palliative care to the gen-
eral public, patients, and families. We designed all inter-
ventions not to require a fundamental change in the
health care system, that is, to optimize the resources
within the region.
To investigate the actual implementation, we regularly
monitor the intensity of interventions by telephone and
visiting the intervention area [18]. In addition, in the
surveys, we investigate the levels of exposure to each
intervention (e.g., whether they used or noticed materi-
als, or they participated in workshops).
Specific interventions
To improve the knowledge and skills of palliative care
providers, we have prepared a pocket-size manual of
palliative care (a book and videos) and 13 assessment
tools (12 educational pamphlets for patients and families
for each symptom, such as pain; and 1 comprehensive
assessment tool). These are provided with printed mate-
rials and a web site. The local leaders are asked to disse-
minate these materials and hold an interactive workshop
to educate them on how to use these materials [25-28].
To increase the availability of specialized palliative
care services for community patients, each region is
asked to establish a community palliative care team
through optimizing the existing resources, because, at
the time of the study, such community palliative care
teams are not available in Japan. In addition, the com-
munity palliative care team provides outreach educa-
tional visits for community intuitions [29].
To coordinate community palliative care resources,
each region is asked to establish a “regional palliative
care center”. The regional palliative care center is then
asked to hold a multidisciplinary conference to develop
collaborative relationships among health care workers in
the region, and share and resolve problems [10,14-16].
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held-records to maintain continuity of care [30], and
facilitate the introduction of a discharge planning system
for all hospitals in the region [31].
To provide appropriate information about palliative
c a r e ,w eh a v ep r e p a r e dah a n d -sized leaflet, note-sized
leaflets, posters, and DVDs about palliative care, and ask
local leaders to put them in public and health care insti-
tutions [32,33]. In addition, local leaders ask public
libraries to provide a “book set” (a set of 100 books
about palliative care), and provide workshops for the
general public. Target themes identified as barriers
include the misconception about cancer pain and
opioids, palliative care, and death at home [33].
Measurements
Questionnaires are sent to patients, bereaved family
members, physicians, and nurses recruited consecutively
following the inclusion criteria by mail. We intend to
obtain the sample as a nearly representative sample of
each region as much as possible.
Subjects
Patients Due to the lack of an established method to
identify all cancer patients living in a specific area in
Japan, we identify all hospitals in the study areas with
reference to hospital lists from the Japan Hospital Asso-
ciation, the largest authorized organization of hospitals
in Japan, and the local resource information. In the pre-
intervention survey, we obtained the participation of a
total of 23 of 34 hospitals treating cancer patients (8,964
beds of 11,033 beds, 81%).
Inclusion criteria are: 1) adult cancer patients with a
primary tumor site in either the lung, esophagus, sto-
mach, colon, rectum, pancreas, liver, biliary system, kid-
n e y ,p r o s t a t e ,b l a d d e r ,b r e a s t ,o v a r y ,o ru t e r u s ,2 )
presence of metastatic or recurrent cancer, 3) outpatient
visits to the oncology department or each specialty divi-
sion, such as respiratory medicine for lung cancer
patients (not palliative care division only), and 4)
informed of malignancy. We have determined to exclude
malignancy of the brain, blood, central nervous system,
neck, soft tissue, and other uncommon primary sites,
due to the infrequent prevalence and increased technical
difficulties in patient recruitment. We have decided to
examine only patients who were informed of malig-
nancy, because we use the term “cancer” in the ques-
tionnaire. Exclusion criteria include: 1) inability of the
patient to complete the questionnaire (dementia, cogni-
tive failure, psychiatric illness, language difficulty, or
visual loss), 2) severe emotional distress of the patient as
determined by the principal treating physicians, and 3)
poor physical condition unable to complete the
questionnaire.
Bereaved family Due to the legal limitation of a mortal-
ity-follow back survey, we identify all hospitals in the
s t u d ya r e a si nt h es a m ew a ya st h ep a t i e n ts u r v e y ,a n d
general practice clinics with experience of caring for
terminally ill cancer patients with reference to the local
resource information.
Inclusion criteria for this bereaved family survey are:
1) bereaved adult family members of an adult cancer
patient who died in the institution or at home (one
family member was selected for each patient), 2) a pri-
mary tumor site of either the lung, esophagus, stomach,
colon, rectum, pancreas, liver, biliary system, kidney,
prostate, bladder, breast, ovary, or uterus, 3) received
medical treatments on at least 3 or more days by the
institution, and 4) informed of malignancy. Exclusion
criteria include: 1) incapacity to complete the question-
naire (dementia, cognitive failure, psychiatric illness, lan-
guage difficulty, or visual loss), 2) severe emotional
d i s t r e s so ft h ef a m i l ya sd e t e r m i n e db yt h ep r i n c i p a l
treating physicians, 3) treatment-associated death or
death from commodity, 4) death in intensive care units,
and 5) family member unavailable.
Physicians and nurses We identify hospitals treating
cancer patients in the same way as the patient survey,
all general practice clinics, and district nurse services.
Inclusion criteria for the physician and nurse survey
are: 1) hospital physicians and nurses working at cancer-
related branches for at least 3 years (internal medicine,
surgery, respiratory medicine, gastro-enterology, urology,
breast cancer, gynecology, hematology, radiation oncol-
ogy, clinical and medical oncology, otopharyncology, and
palliative medicine), 2) representative physicians of gen-
eral practice clinics, and 3) all district nurses.
Outcome Measures (Table 1)
We have determined that this study adopt 4 primary
end-points due to the complex nature of the interven-
tion: 1) number of home deaths, 2) number of patients
who received specialized palliative care services, 3)
patient-reported quality of palliative care, and 4)
bereaved family-reported quality of palliative care [20].
In addition, we adopt multiple end-points to interpret
the results from multiple perspectives.
Location of death We record the number of cancer
patients who died at home, hospitals, and nursing
homes from the national government registry every
year, and, further, the number of patients who died in
palliative care units from each palliative care unit. As
the reference data, we obtain the average rate of home
death in Japan during this study period. The rationale of
setting the number of home deaths as one of the pri-
mary end-points is that, while many patients want to die
at home, home deaths actually occur at a rate of only
6.0% in Japan [24].
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nale of setting the number of patients who received spe-
cialized palliative care services as one of the primary
end-points is that multiple studies revealed the benefi-
cial effects of specialized palliative care services on
patient outcomes [34,35], and, thus, we believe it is rea-
sonable to assume that higher involvement in specialized
palliative care services would result in the improvement
in patient outcomes [36]. To calculate the number of
patients who received specialized palliative care services,
Table 1 Outcome measures
Primary end-points Secondary end-points
Location of death Home death Distribution of location of death (home, hospital,
palliative care units, nursing home)
Use of specialized palliative care
services Patients
Number of patients who received specialized
palliative care services
Backgrounds of patients referred to specialized palliative
care services
Patients
Quality of palliative care Total score of 3 subscales of “physical care provided
by physicians”, “physical care provided by nurses”,
“psycho-existential care) of the Care Evaluation Scale
Care Evaluation Scale
-physical care provided by physicians
-physical care provided by nurses
-psycho-existential care
-help with decision-making
-coordination/consistency of care
Quality of life Good Death Inventory
-physical and psychological comfort
-living in a favorite place
-maintaining hope and pleasure
-having a good relationship with medical staff
-not feeling a burden to others
-having a good relationship with the family
-having independence
-having environmental comfort
-being respected as an individual
-a feeling of fulfillment at life’s completion
Pain Brief Pain Inventory
Satisfaction Satisfaction scale
Knowledge, beliefs, and concerns Knowledge of opioids, Beliefs about palliative care,
Concerns about home care
Feelings of support and security
about cancer care in the region
Bereaved family members
Sense of Security Scale
Bereaved family members
Quality of palliative care Total score of 3 subscales of “physical care provided
by physicians”, “physical care provided by nurses”,
“psycho-existential care) of the Care Evaluation Scale
Care Evaluation Scale
-same as patient, and,
-help with decision making for family
-family care
Quality of life of the patient
(proxy)
Good Death Inventory (same as patient)
Satisfaction Satisfaction scale
Knowledge, beliefs, and concerns Knowledge of opioids, Beliefs about palliative care,
Concerns about home care
Feelings of support and security
about cancer care in the region
Sense of Security Scale
Care burden Caregiving Consequence Inventory
-Burden
Time spent at home Time spent at home
Physicians and nurses Palliative Care Knowledge Test
-philosophy, pain, dyspnea, delirium, and gastro-
intestinal symptoms
Palliative Care Difficulty Scale
-expert support, alleviating symptoms, community
coordination, communication in multidisciplinary teams,
and communication with patients and families
Palliative Care Self-reported practice Scale
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and ask each service to provide a complete patient list
every year. The specialized palliative care service is
defined as “specialized palliative care provided by pallia-
tive care specialists”, including: 1) palliative care unit, 2)
hospital palliative care team, 3) community palliative
care team, 4) outpatient palliative care clinic, and 4)
home palliative care team.
The number of patients who received specialized pal-
liative care services is defined as the total of number of
patients listed in each specialized palliative care service,
and, thus, if one patient received two types of specia-
lized palliative care service, the number of uses of spe-
cialized palliative care services is two. Although we have
acknowledged the non-duplicated counting is ideal, we
gave up on this calculation because not all participating
institutions allow providing patient data beyond the
institutions due to privacy issues. The ratio of the num-
ber of patients who received specialized palliative care
services to all cancer death was calculated.
In addition, to explore whether “early palliative care”
is realized, the backgrounds of patients referred to spe-
cialized palliative care services, such as the performance
status, status of disease-modifying treatment, and con-
sultation aims, are obtained from the patient lists.
Quality of palliative care The quality of palliative care
is measured by both patients and bereaved families
using the Care Evaluation Scale, a well-validated and the
most commonly used measurement tool to quantify the
user-perceived quality of palliative care in Japan [35].
The psychometric properties are established in both
patients and bereaved family members [37,38]. The full
version of the Care Evaluation Scale consists of 8 sub-
scales for patients and 10 subscales for families with a
6-point Likert-type scale from “1: improvement is not
necessary at all” to “6: highly necessary”.O n ei t e m
example is “doctors dealt promptly with discomforting
symptoms of the patient”.F o rt h i ss t u d y ,w eh a v e
excluded 3 subscales, environment, cost, and availability,
because the intervention does not intend to change
these outcomes. For the primary end-points, we use 3
subscales (physical care provided by physicians, physical
care provided by nurses, and psycho-existential care) as
a single scale, because this directly measures the degree
to which patients/family members evaluate medical pro-
fessionals respond to patients’ physical and psychological
distress. All subscales of the Care Evaluation Scale are
used for the secondary end-points.
Quality of life Quality of life is measured by both
patients and bereaved families using the Good Death
I n v e n t o r y ,as p e c i f i cm e a s u r eo ft h eq u a l i t yo fl i f eo f
Japanese patients with advanced cancer [39,40]. We
have decided to use the Good Death Inventory, not
common tools such as EORTC or FACT, because: 1) we
intend to investigate broader areas of quality of life Japa-
nese palliative care populations regard as important,
especially psycho-existential components [41,42], and 2)
existing quality of life measures largely depend on
patient functional levels and previous studies failed to
detect potentially beneficial effects of intervention [4].
The full version of this scale consists of 10 domains
w i t ha7 - p o i n tL i k e r t - t y p es c a l ef r o m“1: strongly dis-
agree” to “7: strongly agree”. One item example is “Ia m
free from physical distress”.T h es u b s c a l e“living in a
favorite place” includes “( t h ep a t i e n t )i sa b l et os t a ya t
his/her favorite place”, and, thus, we can analyze not
only the death location but also whether the death loca-
tion was a preferred place of death of the patients [2].
Satisfaction Satisfaction of the patient and family with
medical care is measured using a single item scale: “Are
you satisfied with the medical care you currently recei-
ve?"with a 6-point Likert-type scale varying from “1:
very dissatisfied” to “6: very satisfied”.
Pain intensity Pain intensity of the patients is measured
using the Japanese version of the Brief Pain Inventory,
with a score given for the pain at its worst (0-10), at its
best (0-10) and a score for the average pain felt (0-10)
over the previous 24 hours. The reliability and validity
in Japanese populations has been established [43].
Knowledge, perceptions, and concerns about pallia-
tive care Knowledge, perceptions, and concerns about
palliative care of the patien t sa n df a m i l i e si sm e a s u r e d
using 10 items, similar to previous surveys [33], on a 5-
point Likert-type scale from 1:strongly disagree to 5:
strongly agree. Knowledge of opioids is examined using
2i t e m s :“opioids can relieve most pain caused by can-
cer” and “opioids are addictive and/or shorten life”.
Beliefs about palliative care are examined using 3 items:
“palliative care relieves pain and distress”, “palliative
care is provided along with chemotherapy and/or radia-
tion therapy”,a n d“palliative care is only for terminally
ill patients”. Concerns about homecare are examined
based on 5 items: “pain can be alleviated as effectively
through home-visit services as it can at the hospital”, “
home - visit services cannot respond to sudden changes
in a patient’s condition”, “it is hard to find home-visiting
physicians”,a n d“being taken care of at home puts a
burden on the family”.
Feelings of support and security regarding cancer care
in the region Feelings of support and security regarding
cancer care in the region are measured by patients and
families using the newly developed Sense of Security
Scale [44]. This is 5-item scale to assess feelings of sup-
port and security concerning cancer care in a region.
One item example is “I would feel secure as a variety of
medical care services are available in the region”.
Care burden Care burden is measured using the Care-
giving Consequences Inventory [45]. The Caregiving
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giving consequences from a bereaved family member’s
perspective, and it consists of 4 positive domains and 1
burden domain. For this study, the burden domain is
used.
T i m es p e n ta th o m eDue to a lack of administrative
data available to calculate time spent at home, we ask
bereaved family members the time spent at home during
the last 1 and 3 months.
Knowledge, difficulty, and self-perceived practice of
palliative care of physicians and nurses Physician-
and nurse-reported knowledge is measured using Pallia-
tive Care Knowledge Test [46]. This scale consists of 5
subscales, with correct, incorrect, and do not know
responses.
Physician- and nurse-reported difficulty of palliative
care is measured with the Palliative Care Difficulty
Scale, a validated tool to quantify the levels of difficulty
when health professionals provide palliative care [47].
This scale consists of 5 subscales with a 5-point Likert-
type scale from 1: never to 5: very much. One item
example is “it is difficult to get support from experts on
alleviating symptoms”.
Physician- and nurse-reported self-perceived practice
is measured employing the Palliative Care Self-reported
Practice Scale, a validated tool to quantify the levels of
adherence to recommended practices in palliative care
fields
47. This scale consists of 6 subscales with a 5-point
Likert-type scale from 1: never to 5: very much. One
item example is “I routinely inquire about the family’s
concerns in the dying phase”.
Quality indicators As quality indicators as region-level
palliative care, we collect 20 quality indicators from
nation-level administrative database, such as opioids
consumption, the number of home care service, the
number of palliative care specialists, and the number of
palliative care units.
Qualitative studies
Qualitative studies consisting of 3 studies.
Descriptive study
A descriptive study is performed to describe the process
in developing regional palliative care in each local con-
text. The study methodology is descriptive case studies,
and this includes a variety of materials each region has
made or arranged for local interventions.
Interview study
This study is performed to understand the process of
how and why the regional palliative care program makes
changes in the region. The ultimate purpose of this
study is to propose a model for shaping regional pallia-
tive care. The research methodology is a grounded the-
ory approach, and the data source is in-depth interviews
with health care professionals.
Systematic collection of barriers and potential resolutions
This study is performed to systemically identify the bar-
riers of palliative care at a regional level and potential
resolutions. The research methodology is content ana-
lyses, and the data source is multiple focus-groups
repeatedly conducted during the entire study period,
field notes, and documents obtained.
Sample size calculations and analyses
As this study have 4 primary-end-points, i.e., the num-
ber of home deaths, use of specialized palliative care ser-
vices, patient-reported quality of palliative care, and
family-reported quality of palliative care, we have set
alpha error of 0.0125 (two-sided) by the Bonferroni cor-
rection for multiple comparisons. All variables are com-
pared between before and after the interventions using
the Student t-test and Chi-square test, where
appropriate.
Patient-reported quality of palliative care and family-
reported quality of palliative care
To detect 0.2 effect size (one-fifth difference of standard
deviation) for quality of palliative care (the Care Evalua-
tion Scale) under statistical power of 0.8, 558 responses
for each pre-intervention and post-intervention period is
required for the analyses
35.W eh a v et h u sd e t e r m i n e d
that 1500 patients and bereaved family members should
be surveyed at each time in consideration of the esti-
mated response rate (40-60%) and missing values (10%)
[35].
The number of home deaths and use of specialized
palliative care services
We first assumed 6% and 8% as each pre-intervention
value from the national data, respectively, and we
expected to achieve 12% and 20% as meaningful
increases after the intervention, respectively; and this
lead to the calculated sample size of 506 and 186 at the
each point, respectively. In practice, as we survey all
cancer death in 4 regions (5000), the sample size is
sufficient.
Discussion
This study is, to our knowledge, one of the most com-
prehensive evaluations of a region-based palliative care
intervention program. This study has 3 major unique
aspects.
First, as an outcome study, this study measures a wide
range of outcomes, enabling comprehensive understand-
ing and interpretation of the results. Especially, this
study is outstanding in terms of: 1) we can obtain
patient and family views as a nearly representative sam-
ple of advanced cancer patients and bereaved family
members in the region; 2) we measure quality of care
and quality of life specifically designed for palliative care
populations, not heavily depending on the functional
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Page 7 of 9status; 3) we can know whether a patient actually died
where they preferred, not only the location of death
itself; and 4) we quantitatively measure the change in
physicians’ and nurses’ knowledge, difficulties, and self-
reported practice at regional levels, especially difficulties
in communicating among local health care professionals.
These efforts are all novel, and would provide useful
insights to disseminate palliative care at regional levels
as well as important information for designing future
intervention studies in this area.
Second, this study adopts a qualitative process
method. Rich description in each local context, under-
standing how the program works in shaping community
palliative care through the grounded theory approach,
and systematic collection of barriers and resolution will
lead to obtaining deep insights into how quality commu-
nity palliative care is developed. We will use the findings
in two ways, namely as a practical guidance for clini-
cians and as an integrated information resource for pol-
icy makers.
Third, the intervention applied in this study is without
a fundamental change in health care systems. This
means the findings from this study would be applicable
to all regions in Japan and probably in other countries,
and clarify what is necessary for community palliative
care as a basis. In other words, after completing this
study, we can plan a randomized controlled trial using
“novel” intervention requiring fundamental changes in
the health care system.
The study analyses will be completed by the end of
2013, and a comprehensive understanding of the find-
ings of this study will contribute to a deeper insight into
how to develop community palliative care.
Acknowledgements
This study is funded by the Third Term Comprehensive Control Research for
Cancer Health and Labour Sciences Research Grant.
Author details
1Department of Palliative and Supportive Care, Palliative Care Team, and
Seirei Hospice, Seirei Mikatahara, General Hospital 3453 Mikatahara-cho,
Hamamatsu, Shizuoka 433-8558, Japan.
2Department of Adult Nursing/
Palliative Care Nursing, School of Health Sciences and Nursing, Graduate,
School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo
113-0033, Japan.
3Department of Adult Nursing/Palliative Care Nursing,
School of Health Sciences and Nursing, Graduate, School of Medicine, The
University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
4Psycho-Oncology Division, Research Center for Innovative Oncology,
National Cancer Center Hospital East 6-5-1, Kashiwanoha, Kashiwa, Chiba
277-8577, Japan.
5Department of Medical Social Service, Center for Palliative
and Supportive Care, Graduate School, University of Tsukuba, 1-1-1 Ten-
nohdai, Tsukuba 305-8575, Japan.
6Shirahige Clinic, 1-13-28, Katafuchi,
Nagasaki, Nagasaki 850-0003, Japan.
7Faculty of Policy Management, Keio
University, 5322 Endo, Fujisawa-shi, Kanagawa 252-8520, Japan.
8Graduate
School of Human Sciences; Center for the Study of Communication-Design;
Department of Complementary and Alternative Medicine, Graduate School
of Medicine, Osaka University, 1-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
9Department of Palliative Medicine and Psycho-Oncology, National Cancer
Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
10Research Center for
Development of Nursing Practice, St. Luke’s College of Nursing 3-8-5 Tsukiji,
Chuo-ku, Tokyo 104-0045, Japan.
11Division of Respiratory Disease, Head of
Regional Support, Kumamoto Takumadai Hospital, 1-14-27 Onoue,
Kumamoto-city, Kumamoto 862-0913, Japan.
12Department of Clinical Trial
Data Management, Graduate School of Medicine, The University of Tokyo,
Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
13School of
Medicine, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1143,
Japan.
Authors’ contributions
TMo led the drafting of this paper and development of the protocol. MMi
and TY co-designed the protocol from the view point of statistical
specialists. AY and TMo co-designed qualitative process studies. NA, YK, MA,
KH, MMa, MY, and YS co-designed the intervention protocol as specialists
and/or local leaders. KE organized the study structure, funded all aspects of
this study, and supervised all phases of this study. All authors read and
approved the final draft.
Competing interests
The authors declare that they have no competing interests.
Received: 8 November 2011 Accepted: 11 January 2012
Published: 11 January 2012
References
1. World Health Organization: National cancer control programmes: Policies
and managerial guidelines second edition. Geneva, WHO 2002.
2. Jordhøy MS, Fayers P, Saltnes T, Ahlner-Elmqvist M, Jannert M, Kaasa S: A
palliative-care intervention and death at home: a cluster randomised
trial. Lancet 2000, 356:888-893.
3. Ringdal GI, Jordhøy MS, Kaasa S: Family satisfaction with end-of-life care
for cancer patients in a cluster randomized trial. J Pain Symptom Manage
2002, 24:53-63.
4. Jordhøy MS, Fayers P, Loge JH, Ahlner-Elmqvist M, Kaasa S: Quality of life
in palliative cancer care: results from a cluster randomized trial. J Clin
Oncol 2001, 19:3884-3894.
5. Fassbender K, Fainsinger R, Brenneis C, Brown P, Braun T, Jacobs P:
Utilization and costs of the introduction of system-wide palliative care
in Alberta, 1993-2000. Palliat Med 2005, 19:513-520.
6. Fainsinger RL, Bruera E, MacMillan K: Innovative palliative care in
Edmonton. Can Fam Physician 1997, 43:1983-1992.
7. Dudgeon DJ, Knott C, Chapman C, Coulson K, Jeffery E, Preston S,
Eichholz M, Van Dijk JP, Smith A: Development, implementation, and
process evaluation of a regional palliative care quality improvement
project. J Pain Symptom Manage 2009, 38:483-495.
8. Dudgeon DJ, Knott C, Eichholz M, Gerlach JL, Chapman C, Viola R, Van
Dijk J, Preston S, Batchelor D, Bartfay E: Palliative care integration project
(PCIP) quality improvement strategy evaluation. J Pain Symptom Manage
2008, 35:573-582.
9. Gómez-Batiste X, Porta-Sales J, Pascual A, Nabal M, Espinosa J, Paz S,
Minguell C, Rodríguez D, Esperalba J, Stjernswärd J, Geli M: Palliative Care
Advisory Committee of the Standing Advisory Committee for Socio-
Health Affairs, Department of Health, Government of Catalonia.
Catalonia WHO palliative care demonstration project at 15 years (2005).
J Pain Symptom Manage 2007, 33:584-590.
10. Shaw KL, Clifford C, Thomas K, Meehan H: Improving end-of-life care: a
critical review of the Gold Standards Framework in primary care. Palliat
Med 2010, 24:317-329.
11. Munday D, Mohmood K, Dale J, King N: Facilitating good process in
primary palliative care: does the Gold Standards Framework enable
quality performance? Fam Pract 2007, 24:486-494.
12. Dale J, Petrova M, Munday D, Koistinen-Harris J, Lall R, Thomas K: A
national facilitation project to improve primary palliative care: impact of
the Gold Standards Framework on process and self-ratings of quality.
Qual Saf Health Care 2009, 18:174-180.
13. Walsh C, Caress A, Chew-Graham C, Todd C: Implementation and impact
of the Gold Standards framework in community palliative care: a
qualitative study of three primary care trusts. Palliat Med 2008,
22:736-743.
14. Kelley ML: Developing rural communities’ capacity for palliative care: a
conceptual model. J Palliat Care 2007, 23:143-153.
Morita et al. BMC Palliative Care 2012, 11:2
http://www.biomedcentral.com/1472-684X/11/2
Page 8 of 915. Masso M, Owen A: Linkage, coordination and integration. Evidence from
rural palliative care. Aust J Rural Health 2009, 17:263-267.
16. Nikbakht-Van de Sande CV, van der Rijt CC, Visser AP, ten Voorde MA,
Pruyn JF: Function of local networks in palliative care: A dutch view.
J Palliat Med 2005, 8:808-816.
17. Lewin S, Glenton C, Oxman AD: Use of qualitative methods alongside
randomised controlled trials of complex healthcare interventions:
methodological study. BMJ 2009, 339:b3496.
18. Oakley A, Strange V, Bonell C, Allen E, Stephenson J, RIPPLE Study Team:
Process evaluation in randomised controlled trials of complex
interventions. BMJ 2006, 332:413-416.
19. Hawe P, Shiell A, Riley T: Complex interventions: how “out of control” can
a randomised controlled trial be? BMJ 2004, 328:1561-1563.
20. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical
Research Council Guidance: Developing and evaluating complex
interventions: the new Medical Research Council guidance. BMJ 2008,
337:a1655.
21. Mitchell G: How well do general practitioners deliver palliative care? A
systematic review. Palliat Med 2002, 16:457-464.
22. Ahmed N, Bestall JC, Ahmedzai SH, Payne SA, Clark D, Noble B: Systematic
review of the problems and issues of accessing specialist palliative care
by patients, carers and health and social care professionals. Palliat Med
2004, 18:525-542.
23. Miyashita M, Sanjo M, Morita T, Hirai K, Kizawa Y, Shima Y, Shimoyama N,
Tsuneto S, Hiraga K, Sato K, Uchitomi Y: Barriers to providing palliative
care and priorities for future actions to advance palliative care in Japan:
a nationwide expert opinion survey. J Palliat Med 2007, 10:390-399.
24. [http://gankanwa.jp/tools/pro/survey.html], (in Japanese).
25. Farmer AP, Légaré F, Turcot L, Grimshaw J, Harvey E, McGowan JL, Wolf F:
Printed educational materials: effects on professional practice and
health care outcomes. Cochrane Database Syst Rev 2008, , 3: CD004398.
26. Goldberg GR, Morrison RS: Pain management in hospitalized cancer
patients: A systematic review. J Clin Oncol 2007, 25:1792-1801.
27. Alvarez MP, Agra Y: Systematic review of educational interventions in
palliative care for primary care physicians. Palliat Med 2006, 20:673-683.
28. Forsetlund L, Bjørndal A, Rashidian A, Jamtvedt G, O’Brien MA, Wolf F,
Davis D, Odgaard-Jensen J, Oxman AD: Continuting education meetings
and workshops: effects on professional practice and health care
outcomes. Cochrane Database Syst Rev 2009, , 2: CD003030.
29. O’Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J,
Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis DA,
Haynes RB, Harvey EL: Educational outreach visits: effects on professional
practice and health care outcomes. Cochrane Database Syst Rev 2007, , 4:
CD000409.
30. Gysels M, Richardson A, Higginson IJ: Does the patient-held record
improve continuity and related outcomes in cancer care: a systematic
review. Health Expect 2006, 10:75-91.
31. Fukui S, Fujita J, Tsujimura M, Sumikawa Y, Hayashi Y, Fukui N: Late
referrals to home care service affecting death at home in advanced
cancer patients in Japan: a nationwide survey. Ann Oncol 2011,
22:2113-2120.
32. Bala M, Strzeszynski L, Cahill K: Mass media interventions for smoking
cessation in adults. Cochrane Database Syst Rev 2008, , 1: CD004704.
33. Morita T, Miyashita M, Shibagaki M, Hirai K, Ashiya T, Ishihara T, Matsubara T,
Miyoshi I, Nakaho T, Nakashima N, Onishi H, Ozawa T, Suenaga K, Tajima T,
Akechi T, Uchitomi Y: Knowledge and beliefs about end-of-life care and
the effects of specialized palliative care: a population-based survey in
Japan. J Pain Symptom Manage 2006, 31:306-316.
34. Higginson IJ, Finlay IG, Goodwin DM, Hood K, Edwards AG, Cook A,
Douglas HR, Normand CE: Is there evidence that palliative care teams
alter end-of-life experiences of patients and their caregivers? J Pain
Symptom Manage 2003, 25:150-168.
35. Miyashita M, Morita T, Hirai K: Evaluation of end-of-life cancer care from
the perspective of bereaved family members: the Japanese experience. J
Clin Oncol 2008, 26:3845-3852.
36. Casarett D, Karlawish J, Morales K, Crowley R, Mirsch T, Asch DA: Improving
the use of hospice services in nursing homes: a randomized controlled
trial. JAMA 2005, 294:211-217.
37. Morita T, Hirai K, Sakaguchi Y, Maeyama E, Tsuneto S, Shima Y: Measuring
the quality of structure and process in end-of-life care from the
bereaved family perspective. J Pain Symptom Manage 2004, 27:492-501.
38. Miyashita M, Wada M, Morita T, Matoba M, Tsuneto S, Shima Y: Reliability
and Validity of the Care Evaluation Scale patient version. Proceedings of
the 15th congress of Japanese Society of Palliative Medicine, Tokyo 2010, 165.
39. Miyashita M, Morita T, Sato K, Shima Y, Uchitomi Y: Good Death Inventory:
A measure for evaluating good death from the bereaved family
member’s perspective. J Pain Symptom Manage 2008, 35:486-498.
40. Miyashita M, Wada M, Morita T, Matoba M, Tsuneto S, Shima Y: Reliability
and Validity of the Good Death Inventory patient version. Proceedings of
the 15th congress of Japanese Society of Palliative Medicine, Tokyo 2010, 165.
41. Hirai K, Miyashita M, Morita T, Sanjo M, Uchitomi Y: Good death in
Japanese cancer care: a qualitative study. J Pain Symptom Manage 2006,
31:140-147.
42. Miyashita M, Sanjo M, Morita T, Hirai K, Uchitomi Y: Good death in cancer
care: a nationwide quantitative study. Ann Oncol 2007, 18:1090-1097.
43. Uki J, Mendoza T, Cleeland CS, Nakamura Y, Takeda F: A brief cancer pain
assessment tool in Japanese: the utility of the Japanese Brief Pain
Inventory–BPI-J. J Pain Symptom Manage 1998, 16:364-373.
44. Igarashi A, Miyashita M, Morita T, Akizuki N, Akiyama M, Shirahige Y,
Eguchi K: A scale for measuring feelings of support and security about
cancer care in a region of Japan: a potential new endpoint of palliative
care. J Pain Symptom Manage 2011.
45. Sanjo M, Morita T, Miyashita M, Shiozaki M, Sato K, Hirai K, Shima Y,
Uchitomi Y: Caregiving Consequences Inventory: a measure for
evaluating caregiving consequences from the bereaved family
member’s perspective. Psychooncology 2009, 18:657-666.
46. Nakazawa Y, Miyashita M, Morita T, Umeda M, Oyagi Y, Ogasawara T: The
palliative care knowledge test: reliability and validity of an instrument to
measure palliative care knowledge among health professionals. Palliat
Med 2009, 23:754-766.
47. Nakazawa Y, Miyashita M, Morita T, Umeda M, Oyagi Y, Ogasawara T: The
palliative care self-reported practices scale and the palliative care
difficulties scale: reliability and validity of two scales evaluating self-
reported practices and difficulties experienced in palliative care by
health professionals. J Palliat Med 2010, 13:427-437.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-684X/11/2/prepub
doi:10.1186/1472-684X-11-2
Cite this article as: Morita et al.: A region-based palliative care
intervention trial using the mixed-method approach:
Japan OPTIM study. BMC Palliative Care 2012 11:2.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Morita et al. BMC Palliative Care 2012, 11:2
http://www.biomedcentral.com/1472-684X/11/2
Page 9 of 9